Search results
How Anti-Obesity Drugs Are Innovating the Healthcare Market
Morningstar· 7 days agoOn this episode of The Long View, Morningstar’s Damien Conover and Rebecca Springer discuss investing in healthcare in public and private markets, healthcare consumerization, and the impact ...
More Weight Loss With Anti-Obesity Meds and Hormone Therapy?
Medscape· 1 day ago"To date, there are no studies comparing weight loss outcomes to any of the anti-obesity...
Weight-loss drugs help lift pharma's reputation
Axios· 20 hours agoThe blockbuster success of new anti-obesity drugs helped boost the corporate reputations of pharmaceutical brands, according to new rankings from the annual Axios/Harris Poll 100. Why it matters ...
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 Years and Support Heart Health
Verywell Health via Yahoo News· 2 days ago“This finding shifts our understanding, emphasizing semaglutide’s potential as a cardiovascular...
Nestlé to debut Vital Pursuit healthy food brand for Ozempic, Wegovy medication users
USA TODAY via Yahoo News· 2 days agoNestlé is launching a new food line next year meant to support Americans who use weight-management...
Wegovy, Saxenda study reveals surprising trend for weight loss drugs
USA Today· 3 days agoMore than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended...
Nestlé introduced a new frozen food brand aimed at weight-loss drug users
Axios· 2 days agoNestlé on Tuesday announced a new frozen food brand aimed at weight-loss drug users in one of the...
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful...
Fortune via AOL· 2 days agoAs recently as the onset of COVID-19 four years ago, you probably didn’t know what a glucagon-like...
3 Monster Stocks in the Making You Can Buy Right Now
Motley Fool via Yahoo Finance· 6 days agoIf you go to California's Redwood National Park, you can see the world's tallest tree -- a redwood called Hyperion that's over 380 feet tall. Like every...
AstraZeneca aims for $80 billion in total revenue by 2030
Colorado Springs Gazette· 3 days agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. CEO Pascal Soriot has turned ...
